Maternal Cardiac Disease Flashcards
Define gHTN
BP >/= 140/90 >/= 20 weeks on 2 occasions at least 4 hours apart
AND
-No history of hypertension
-No history of proteinuria
-No severe features of preeclampsia
Define preeclampsia and what features are severe
BP >/= 140/90 >/= 20 weeks at least 4 hours apart
AND
-Proteinuria (P/C >/= 0.3 or >/=300mg/24hr)
—— severe features—–
-Thrombocytopenia, < 100k
-Renal insufficiency, Cr >1.1mg/dL or 2x baseline
-Impaired liver function, 2x upper limit normal AST or ALT
-Pulmonary edema
-Cerebral or visual symptoms
-Refractory RUQ/epigastric pain
Incidence of hypertensive disease of pregnancy
4% pregnancies in US
Those recommended to use prophylactic LDA and dosing
- 1 or more high risk factors (=8% risk of pree)
OR
-2 or more moderate risk factors
81mg daily >/=12 -28 weeks-, ideally before 16 weeks
High risk factors for LDA therapy
- History of preeclampsia
- Multifetal gestation
- Renal disease
- Chronic hypertension
- Pregestational diabetes
- Autoimmune disease (SLE, APS)
Moderate risk factors for LDA therapy
- Age >35
- Nulliparity
- BMI >30 kg/m2
- Black race
- Mother or sister with preeclampsia
- Low income
- IVF pregnancy
- History – SGA, adverse pregnancy outcome, pregnancy interval >10years
LDA reduces the rate of
- Preeclampsia ~50%
- Fetal growth restriction~60%
- Medically indicated preterm birth before 35 weeks
Contraindications to expectant management of preeclampsia
- uncontrolled severe range BP
- refractory headache
- refractory RUQ/epigastric pain
- visual disturbances
- pulmonary edema
- HELLP
- eclampsia
- Renal dysfunction
- MI
- Stroke
- placental abruption
- abnormal fetal testing
- fetal death or lethal anomaly
- REDF
Long term health risks of preeclampsia
-2-3x risk of developing CVD (CAD, MI, HF and stroke)
-Offspring effects (DM, HTN, neurodevelopmental)
Time frame for BP check after preeclampsia discharge
within 72hrs
Risk of gHTN developing preeclampsia
50%
HELLP diagnsosi
- Hemolysis - LDH >600 IU/L
- LFT dysfunction - AST/ALT 2x upper limit of normal
- Thrombocytopenia - <100k
15% without HTN or proteinuria
Typical main symptoms with HELLP
RUQ pain, generalized malaise, nausea, vomiting
Define eclampsia
new onset, tonic-clonic/focal/multifocal seizures in the absence of other causative conditions (epilepsy, cerebral ischemia/infarct, ICH, drug use)
Cause of maternal mortality with eclampsia
maternal hypoxia, trauma, aspiration pneumonia
Is there residual neuro damage after eclampsia
Rarely – some women have short and long term memory and/or cognitive impairment
Are there usual premonitory signs of eclampsia
Yes – headache, blurred vision, photophobia, altered mental status
Some cases without htn or proteinuria or any premonitory signs
Cause of headache in htn disorder/eclampsia
elevated cerebral perfusion pressure, cerebral edema, hypertensive encephalopathy
Define PRES
Posterior reversible encephalopathy syndrome
abnormal nervous system manifestations vision loss or deficit, seizure, headache, altered sensorium or confusion
How is diagnosis of PRES made
vasogenic edema and hyperintensities in the posterior aspect of the brain on MRI
Treatment of PRES
same as preeclampsia
Which LFT is usually more elevated first in preeclampsia and why
AST due to periportal necrosis
In general, evaluation of coagulation factors in preeclampsia is indicated when
Thrombocytopenia, significant liver dysfunction, placental abruption
Cause of proteinuria in preeclampsia
increased tubular permeability to proteins
What happens to urinary Ca in preeclampsia
Decreases because there is increased tubular resporption
What causes renal sodium and water retention in preeclampsia
the intravascular depletion, vasoconstriction leads to decreased renal perfusion
What are some fetal consequences of preeclampsia and mechanism
Impaired uteroplacental blood flow – fetal growth restriction, non-reassuring fetal status, oligohydramnios, abruption, preterm delivery, hypoxia-acidosis, neurologic injury, death
Mechanism of LDA in pree prevention
Inhibition of thromboxane A2
Magnesium decreases risk of seizure how much…decrease or increase anything else?
Decrease eclampsia by ~50%
Reduced risk of placental abruption
Maternal side effects in 25%
5% increased rate of CD
Rate of eclampsia in preeclampsia with severe features
4 in 200 without magnesium
1 in 200 with magnesium
Number needed to treat with Mag to prevent eclampsia
Pree with severe features - 129
Pree with severe features and symptomatic - 36
Contraindications to Mag
Myasthenia gravis
Hypocalcemia
Severe renal failure
Cardiac ischemia
Heart block
Myocarditis
Mag therapeutic/toxic levels
5-9 mg/dL therapeutic
> 9 loss of DTR
>12 respiratory compromise
>30 cardiac arrest
toxicities due to its action as a smooth muscle relaxant
Magnesium dosing
4g bolus over 20-30 minutes
1-2g/hr